On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayMar 13, 2017 2:00 pm

MacroGenics, Inc. (NASDAQ: MGNX) Starts Presentation at 29th Annual ROTH Conference

MacroGenics (NASDAQ: MGNX) is a biopharmaceutical company focused on discovering and developing antibody-based therapeutics for the treatment of cancer primarily by modulating the human immune system, as well as various autoimmune disorders and infectious diseases. Its advanced clinical product candidate is Margetuximab, a monoclonal antibody that is in Phase III clinical trial, which targets human epidermal growth factor receptor 2-expressing tumors, including certain types of breast and gastroesophageal cancers. The company also develops Enoblituzumab, an antibody that is in phase 1 clinical trial as monotherapy in multiple dose expansion cohorts; and MGD006, a DART molecule that targets CD123 and CD3.…

Continue Reading

MondayMar 13, 2017 1:30 pm

Inphi Corp. (NYSE: IPHI) Starts Presentation at 29th Annual ROTH Conference

Inphi (NYSE: IPHI) is engaged in high-speed data movement. The company quickly moves big data throughout the globe between data centers, and inside data centers. Inphi's expertise in signal integrity results in reliable data delivery, at high speeds, over a variety of distances. As data volumes ramp exponentially due to video streaming, social media, cloud-based services, and wireless infrastructure, the need for speed has never been greater.  Customers rely on Inphi's solutions to develop and build out the service provider and cloud infrastructures, and data centers of tomorrow. For more information, visit the company’s website at www.inphi.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

MondayMar 13, 2017 1:30 pm

Hudson Technologies, Inc. (NASDAQ: HDSN) Starts Presentation at 29th Annual ROTH Conference

Hudson Technologies (NASDAQ: HDSN) provides innovative solutions to recurring problems within the refrigeration industry. Hudson's proprietary RefrigerantSide® Services increase operating efficiency and energy savings, and remove moisture, oils and other contaminants frequently found in the refrigeration circuits of large comfort cooling and process refrigeration systems. Performed at a customer's site as an integral part of an effective scheduled maintenance program or in response to emergencies, RefrigerantSide® Services offer significant savings to customers due to their ability to be completed rapidly and at higher purity levels, and can be utilized while the customer's system continues to operate. In addition, the company sells refrigerants and provides…

Continue Reading

MondayMar 13, 2017 1:30 pm

Kite Pharma, Inc. (NASDAQ: KITE) Starts Presentation at 29th Annual ROTH Conference

Kite Pharma (NASDAQ: KITE) is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies. The company aims to achieve its goal of providing rapid, long-term durable response and eliminating the burden of chronic care through the development of cancer immunotherapies. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information, visit the company’s website at www.kitepharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

Continue Reading

MondayMar 13, 2017 1:30 pm

Natus Medical, Inc. (NASDAQ: BABY) Starts Presentation at 29th Annual ROTH Conference

Natus Medical (NASDAQ: BABY) designs, manufactures and markets newborn care and neurology healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography,and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. For more information, visit the company’s website at www.natus.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press…

Continue Reading

MondayMar 13, 2017 1:30 pm

The Ultimate Software Group, Inc. (NASDAQ: ULTI) Starts Presentation at 29th Annual Roth Conference

The Ultimate Software Group (NASDAQ: ULTI) provides cloud-based human capital management solutions primarily to enterprise companies in the United States. Its UltiPro software solution delivers the functionality businesses to manage the employee life cycle from recruitment to retirement. The company’s UltiPro solution includes unified feature sets for talent acquisition and on boarding, human resources management and compliance, benefits management and online enrollment, payroll, performance management, salary planning and budgeting for compensation management, development of incentive plans, succession management, reporting and analytical decision-making and predictive tools, and time and attendance; and has role-based features for human resources professionals, executives, managers, administrators,…

Continue Reading

MondayMar 13, 2017 1:30 pm

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) Starts Presentation at 29th Annual ROTH Conference

Foamix Pharmaceuticals (NASDAQ: FOMX) is a specialty pharmaceutical company focused on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. The company’s clinical stage product candidates include FMX101, a novel minocycline foam for the treatment of moderate-to-severe acne; FMX103 for the treatment of moderate-to-severe rosacea; FMX102 for the treatment of impetigo; and FDX104, a doxycycline foam for the management of acne-like rash induced by EGFRI anticancer drugs. In addition, Foamix has development and license agreements relating to its technology with various pharmaceutical companies including Bayer HealthCare and others. For more information, visit the company’s website…

Continue Reading

MondayMar 13, 2017 1:25 pm

ORHub, Inc.’s (ORHB) Surgical Resource Management Platform Aims to Revolutionize Surgical Care

With health care costs constantly on the rise across all medical sectors, a growing number of health care professionals and practices are looking for ways to streamline and improve their processes via electronic management technologies, so as to ultimately offer more efficient and cost-effective services. Whether it’s electronic medical records, revenue cycle management, scheduling and billing software, or more, cloud-based technologies are becoming increasingly popular in the health care niche, proving to be a very effective replacement for the traditional manual systems. One segment that is largely unaddressed, but which would particularly benefit from a more complex and comprehensive digital…

Continue Reading

MondayMar 13, 2017 1:00 pm

Aduro BioTech, Inc. (NASDAQ: ADRO) Starts Presentation at 29th Annual ROTH Conference

Aduro Biotech (NASDAQ: ADRO) is an immunotherapy company focused on the discovery, development and commercialization of therapies that transform the treatment of challenging diseases. Aduro's technology platforms, which are designed to harness the body's natural immune system, are being investigated in cancer indications and have the potential to expand into autoimmune and infectious diseases. Aduro's LADD technology platform is based on proprietary attenuated strains of Listeria that have been engineered to express tumor-associated antigens to induce specific and targeted immune responses and is being developed as a treatment for multiple indications, including ovarian, lung and prostate cancers, and mesothelioma. Additionally,…

Continue Reading

MondayMar 13, 2017 1:00 pm

Align Technology, Inc. (NASDAQ: ALGN) Starts Presentation at 29th Annual ROTH Conference

Align Technology (NASDAQ: ALGN) is provider of clear aligner orthodontics that designs, manufactures and markets the Invisalign® system, which provides dental professionals with a range of  treatment options for adults and teenagers. Align also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align was founded in March 1997 and received FDA clearance to market the Invisalign system in 1998. For more information, visit the company’s website at www.aligntech.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217